Lindbrook Capital’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$3.69K Buy
209
+188
+895% +$3.77K ﹤0.01% 2079
2024
Q4
$510 Buy
21
+20
+2,000% +$571 ﹤0.01% 2617
2024
Q3
$37 Sell
1
-57
-98% -$2.13K ﹤0.01% 2808
2024
Q2
$2.76K Buy
+58
New +$2.54K ﹤0.01% 2244
2024
Q1
Sell
-210
Closed -$6.55K 2753
2023
Q4
$6.55K Sell
210
-133
-39% -$4.78K ﹤0.01% 1746
2023
Q3
$13.8K Buy
343
+257
+299% +$12K ﹤0.01% 1249
2023
Q2
$4.52K Sell
86
-133
-61% -$8.1K ﹤0.01% 1852
2023
Q1
$14K Sell
219
-49
-18% -$3.2K ﹤0.01% 1245
2022
Q4
$13K Sell
268
-120
-31% -$7.53K ﹤0.01% 1297
2022
Q3
$27K Buy
388
+110
+40% +$9.41K ﹤0.01% 869
2022
Q2
$20K Buy
278
+75
+37% +$4.83K ﹤0.01% 971
2022
Q1
$16K Sell
203
-446
-69% -$33.2K ﹤0.01% 1109
2021
Q4
$59K Buy
+649
New +$69.6K 0.01% 666

Other funds holding STAA

Lindbrook Capital's STAA Position: Q1 2025 in Review

Lindbrook Capital increased its STAAR Surgical (STAA) stake by 895% in Q1 2025, buying an estimated $3.77K and bringing the position to 209 shares worth $3.69K. The position accounts for ﹤0.01% of the portfolio, ranked #2079.

Lindbrook Capital first reported a position in STAA in Q4 2021 and has held it in 13 quarters since. The position peaked at $59K in Q4 2021. 185 funds tracked by Wall St. Rank hold STAA as of Q1 2025.

  • Lindbrook Capital held 209 shares of STAAR Surgical worth $3.69K as of Q1 2025.
  • Lindbrook Capital bought 188 STAAR Surgical shares in Q1 2025, an estimated $3.77K.
  • STAAR Surgical made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2079 holding.
  • Lindbrook Capital first reported a position in STAAR Surgical in Q4 2021 and has held it in 13 quarters since.
  • Lindbrook Capital's STAAR Surgical position peaked at $59K in Q4 2021.
  • 185 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.